EGFR mutations cause a lethal syndrome of epithelial dysfunction with progeroid features
Open Access
- 4 June 2015
- journal article
- research article
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 3 (5) , 452-458
Abstract
The epidermal growth factor receptor (EGFR) is part of a large family of receptors required for communicating extracellular signals through internal tyrosine kinases. Epidermal growth factor (EGF) signaling is required for tissue development, whereas constitutive activation of this signaling pathway is associated with oncogenic transformation. We identified homozygous c.1283G>A (p.Gly428Asp) mutations in the extracellular domain of EGFR in two siblings. The children were born prematurely, had abnormalities in skin and hair, suffered multisystem organ failure, and died in the neonatal period from intestinal perforation. EGF failed to induce mutated receptor phosphorylation in patient‐derived fibroblasts and activation of downstream targets was suppressed. The heterologously expressed extracellular domain was impaired in stability and the binding of EGF. Cells from the affected patient undergo early senescence with accelerated expression of β‐galactosidase and shortened telomeres at all passages when compared to controls. A comparison of homozygous inherited regions from a separate report of a patient from the same ethnic background and EGFR genotype confirms the pathogenicity of EGFR mutations in congenital disease.Keywords
Funding Information
- National Institutes of Health (5T32GM008638-18, T32-GM0082075)
- Foerderer Foundation of the Children's Hospital of Philadelphia (R01-CA079992)
This publication has 13 references indexed in Scilit:
- Epithelial Inflammation Resulting from an Inherited Loss-of-Function Mutation in EGFRJournal of Investigative Dermatology, 2014
- Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung CancerScience Signaling, 2013
- Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancerNature Reviews Cancer, 2010
- Dermatologic side effects associated with the epidermal growth factor receptor inhibitorsJournal of the American Academy of Dermatology, 2006
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Extracellular domains drive homo‐ but not hetero‐dimerization of erbB receptorsThe EMBO Journal, 2000
- RTK mutations and human syndromes: when good receptors turn badTrends in Genetics, 2000
- Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development.1997
- The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase.Genes & Development, 1994
- Down-regulation of the epidermal growth factor receptor in KB cells is due to receptor internalization and subsequent degradation in lysosomes.Proceedings of the National Academy of Sciences, 1984